Riskpilot← Back to searchSign inGet full accessCOMMERCE PHARMA HOLDING ApS
APSActiveCVR 30273648Gyldenlundsvej 21, 1.Business and other management consultancy activities · NACE 7020Est. 20071 employees
Revenue 2024
DKK 411K
-1343% vs 2023
EBITDA margin
100.0%
+907% vs 2023
Equity ratio
60.9%
Financial strength
Net profit 2024
DKK 268K
+521% vs 2023
| Revenue | DKK 411K | -1343% |
| EBITDA | DKK 411K | +907% |
| Net profit | DKK 268K | +521% |
| Total assets | DKK 758K | +56% |
| Equity | DKK 462K | +49% |
| Employees | 1 | — |
Legal name
COMMERCE PHARMA HOLDING ApS
CVR number
30273648
Legal form
Anpartsselskab
NACE code
7020 · Business and other management consultancy activities
Founded
13. februar 2007
Share capital
DKK 132.000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af én direktør
Company purpose
Selskabets formål er at drive virksomhed gennem datterselskaber og investering
Address
Gyldenlundsvej 21, 1.
Phone
+4551868482
Email
bt@vanadis.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | -7 | -6 | -6 | — | 50 | 140 | 79 | 637 | 2.832 | 98 | 123 | -33 | 411 |
| Staff expenses | -0 | -0 | -0 | -0 | -16 | -9 | -18 | -639 | -527 | -109 | -6 | -18 | -0 |
| EBITDA | -7 | -6 | -6 | 228 | 34 | 130 | 62 | -2 | 2.304 | -11 | 37 | -51 | 411 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -6 | -5 | -6 | -7 | -6 |
| EBIT | -7 | -6 | -6 | 228 | 34 | 130 | 62 | -2 | 2.298 | -16 | 31 | -58 | 405 |
| Net financials | -8 | -11 | -10 | -14 | -3 | -342 | -0 | 8 | -1 | 7 | -4 | -5 | -70 |
| Profit before tax | -15 | -17 | -16 | 215 | 30 | -212 | 61 | 6 | 2.297 | -9 | 27 | -64 | 334 |
| Tax | -0 | -0 | -0 | 32 | 7 | -0 | -0 | -0 | 342 | 2 | 11 | -0 | 66 |
| Net profit | -15 | -17 | -16 | 183 | 23 | -212 | 61 | 6 | 1.955 | -11 | 15 | -64 | 268 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 342 | 457 | 355 | 466 | 415 | 102 | 131 | 201 | 787 | 576 | 513 | 486 | 758 |
| Equity | 86 | 69 | 53 | 236 | 259 | 48 | 109 | 115 | 370 | 359 | 375 | 311 | 462 |
| Long-term debt | 0 | 0 | 0 | 0 | 104 | 41 | 0 | 69 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 256 | 387 | 302 | 230 | 51 | 13 | 22 | 17 | 417 | 217 | 138 | 175 | 296 |
| Total debt | 256 | 387 | 302 | 230 | 155 | 54 | 22 | 85 | 417 | 217 | 138 | 175 | 296 |
EBITDA margin
100.0%
This company
15.8%
Market median
+533% vs market
20122024
Equity ratio
60.9%
This company
38.2%
Market median
+59% vs market
20122024
Return on equity
58.0%
This company
18.4%
Market median
+215% vs market
20122024
Net profit margin
65.2%
This company
8.1%
Market median
+705% vs market
20122024
Asset turnover
0.54×
This company
1.12×
Market median
-52% vs market
20122024
Debt / equity
0.64×
This company
0.62×
Market median
+3% vs market
20122024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
No data on file.
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100.0% | 100.0% | 2007 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
COMMERCE PHARMA HOLDING ApS (this company)
Vanadis ApSBoard members of COMMERCE PHARMA HOLDING ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|